Northern Trust’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
VC
BCM
VCM
UOTTAIMCU
CCC
PM
SPC
TCBWMS
GS
Northern Trust's RNTX Position: Q1 2026 in Review
Northern Trust increased its Rein Therapeutics (RNTX) stake by 58% in Q1 2026, buying an estimated $29.4K and bringing the position to 64,136 shares worth $83.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4144.
Northern Trust first reported a position in RNTX in Q3 2017 and has held it in 20 quarters since. The position peaked at $254K in Q3 2017. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.
- Northern Trust held 64,136 shares of Rein Therapeutics worth $83.4K as of Q1 2026.
- Northern Trust bought 23,667 Rein Therapeutics shares in Q1 2026, an estimated $29.4K.
- Rein Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4144 holding.
- Northern Trust first reported a position in Rein Therapeutics in Q3 2017 and has held it in 20 quarters since.
- Northern Trust's Rein Therapeutics position peaked at $254K in Q3 2017.
- 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.